Risk Factors for Autoimmune Hepatitis: From Genesand Pregnancy to Vaccinations and Pollutants

10.7178/ig.32 ◽  
2013 ◽  
Vol 2 (1) ◽  
pp. 29 ◽  
Author(s):  
Daniel S Smyk ◽  
2011 ◽  
Vol 47 (5) ◽  
pp. 569-576 ◽  
Author(s):  
Teruko Hino-Arinaga ◽  
◽  
Tatsuya Ide ◽  
Ryoko Kuromatsu ◽  
Ichiro Miyajima ◽  
...  

2007 ◽  
Vol 28 (2) ◽  
pp. 202-204 ◽  
Author(s):  
Dominique Vanjak ◽  
Guillaume Girault ◽  
Catherine Branger ◽  
Pierre Rufat ◽  
Dominique-Charles Valla ◽  
...  

During 2001,Clostridium difficileinfection was observed in 23 patients hospitalized in a hepatology ward (attack rate, 0.9%). Since strain typing ruled out a clonal dissemination, we performed a case-control study. In addition to antibiotic use as a risk factor, theC. difficileinfection rate was higher among patients with autoimmune hepatitis (P< .01).


2009 ◽  
Vol 15 (10) ◽  
pp. 1254-1261 ◽  
Author(s):  
Aldo J. Montano-Loza ◽  
Andrew L. Mason ◽  
Mang Ma ◽  
Ravin J. Bastiampillai ◽  
Vincent G. Bain ◽  
...  

2010 ◽  
Vol 46 (S1) ◽  
pp. 56-62 ◽  
Author(s):  
Kiyoshi Migita ◽  
Yukio Watanabe ◽  
Yuka Jiuchi ◽  
Yoko Nakamura ◽  
Akira Saito ◽  
...  

2020 ◽  
Author(s):  
Vahin Vuppalanchi ◽  
Kelsey Green ◽  
Kayla Gelow ◽  
Raj Vuppalanchi ◽  
Craig Lammert

BACKGROUND It is currently unknown if patients with autoimmune hepatitis (AIH) and cirrhosis on immunosuppression are at high risk for severe COVID-19 illness. The study aims were to examine the differences in known risk factors and AIH-related factors in those who experienced symptoms consistent with COVID-19 illness versus those who did not. OBJECTIVE The study aims were to examine the differences in known risk factors and AIH-related factors in those who experienced symptoms consistent with COVID-19 illness versus those who did not METHODS An invitation to complete a COVID-19 specific questionnaire was electronically promoted four times between April 28th and May 16th of 2020, and posted four separate times to well-established AIH patient social media cohorts. Eligibility criteria for survey participants included age ≥ 18 years, United States residency, and an AIH diagnosis by a physician. A total of 478 survey responses were received, and 420 were eligible for the study. RESULTS Symptoms consistent with COVID-19 illness were reported in 11% (n=48) with three patients requiring hospitalizations. BMI >40 kg/m2 (23% vs. 10%, P = 0.01) and exposure to house (33% vs. 3%, P = 0.0001) or work (38% vs. 17%, P = 0.02) contacts with COVID-19 illness were factors found significantly higher in the group with symptoms. The presence of cirrhosis or use of steroid or immune suppressants was not significantly different between the symptomatic and non-symptomatic groups. Worsening fatigue (45% vs. 30%, P = 0.06), anxiety (89% vs. 70%, P = 0.08), and itch (40% vs. 18%, P = 0.03) were more common among AIH patients reporting COVID-19 symptoms compared to those withoutBMI >40kg/m2 and exposure to contacts with COVID-19 illness but not cirrhosis or immunosuppression were associated with increased risk of COVID-19 illness in patients with AIH. CONCLUSIONS BMI >40kg/m2 and exposure to contacts with COVID-19 illness but not cirrhosis or immunosuppression were associated with increased risk of COVID-19 illness in patients with AIH. CLINICALTRIAL n/a


2021 ◽  
Author(s):  
Craig Lammert ◽  
Sai N Chalasani ◽  
Elizabeth J. Atkinson ◽  
Bryan M. McCauley ◽  
Konstantinos N. Lazaridis

Sign in / Sign up

Export Citation Format

Share Document